LinkedIn

آمار

تعداد نشریات20
تعداد شماره‌ها995
تعداد مقالات9,123
تعداد مشاهده مقاله10,670,197
تعداد دریافت فایل اصل مقاله5,133,055
Niknahad, Hossein, Abdoli, Narges, Ommati, Mohammad Mehdi, Najibi, Asma, Zare, Ardeshir, Mazloomi, Sahra, Sadeghian, Issa, Mousavi, Khadijeh, Azarpira, Negar, Heidari, Reza. (1401). Dexamethasone blunts lung inflammation in cholestatic mice. سامانه مدیریت نشریات علمی, 9(1), -. doi: 10.30476/tips.2022.96046.1155
Hossein Niknahad; Narges Abdoli; Mohammad Mehdi Ommati; Asma Najibi; Ardeshir Zare; Sahra Mazloomi; Issa Sadeghian; Khadijeh Mousavi; Negar Azarpira; Reza Heidari. "Dexamethasone blunts lung inflammation in cholestatic mice". سامانه مدیریت نشریات علمی, 9, 1, 1401, -. doi: 10.30476/tips.2022.96046.1155
Niknahad, Hossein, Abdoli, Narges, Ommati, Mohammad Mehdi, Najibi, Asma, Zare, Ardeshir, Mazloomi, Sahra, Sadeghian, Issa, Mousavi, Khadijeh, Azarpira, Negar, Heidari, Reza. (1401). 'Dexamethasone blunts lung inflammation in cholestatic mice', سامانه مدیریت نشریات علمی, 9(1), pp. -. doi: 10.30476/tips.2022.96046.1155
Niknahad, Hossein, Abdoli, Narges, Ommati, Mohammad Mehdi, Najibi, Asma, Zare, Ardeshir, Mazloomi, Sahra, Sadeghian, Issa, Mousavi, Khadijeh, Azarpira, Negar, Heidari, Reza. Dexamethasone blunts lung inflammation in cholestatic mice. سامانه مدیریت نشریات علمی, 1401; 9(1): -. doi: 10.30476/tips.2022.96046.1155

Dexamethasone blunts lung inflammation in cholestatic mice

Trends in Pharmaceutical Sciences
مقاله 1، دوره 9، شماره 1، خرداد 2023  XML
نوع مقاله: Original Article
شناسه دیجیتال (DOI): 10.30476/tips.2022.96046.1155
نویسندگان
Hossein Niknahadorcid 1؛ Narges Abdoli2؛ Mohammad Mehdi Ommati3؛ Asma Najibiorcid 4؛ Ardeshir Zare5؛ Sahra Mazloomi6؛ Issa Sadeghian5؛ Khadijeh Mousavi6؛ Negar Azarpiraorcid 7؛ Reza Heidari email orcid 8
1Department of Pharmacology-Toxicology, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran.
2Food and Drug Administration, Iran Ministry of Health and Medical Education, Tehran, Iran
3College of Life Sciences, Shanxi Agricultural University, Taigu, Shanxi 030801, China
4Department of Pharmacology and Toxicology, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran.
5Pharmaceutical Sciences Research Center, Shiraz University Of Medical Sciences, Shiraz, Iran
6Pharmaceutical Sciences Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
7Transplant Research Center, Shiraz University of Medical Sciences
8Shiraz University of Medical Sciences, Pharmaceutical Sciences Research Center
چکیده
Cholestasis/cirrhosis is a multifaceted clinical complication that influences many organs, including the liver, kidney, heart, skeletal muscle, and lung. Cirrhosis-associated lung injury could lead to severe and lethal consequences, including acute respiratory syndrome and patient dearth. Unfortunately, there is no specific pharmacological intervention to manage cholestasis-induced lung injury. It has been revealed that severe inflammation and its associated complications, such as oxidative stress, are involved in the pathogenesis of cholestasis-associated pulmonary damage. The current study was designed to evaluate the role of dexamethasone (DXM) on lung inflammation in cholestatic mice. For this purpose, bile duct ligated (BDL) mice received DXM (1 and 2.5 mg/kg, i.p, 2 times/week) for 14 days. On day 15, the bronchoalveolar lavage fluid (BALF) was prepared. Several markers, including inflammatory cell infiltration, TNF-α, and IgG, were assessed in the BALF of BDL animals. Significant infiltration of inflammatory cells along with increased TNF-α and IgG were detected in the BALF of BDL mice (14 days after surgery). Moreover, significant ROS formation, glutathione depletion, lipid peroxidation, and protein carbonylation were evident in the lung tissue of the BDL group. It was found that DXM (1 and 2.5 mg/kg) significantly blunted inflammation and oxidative stress in the lung of cholestatic mice. Moreover, lung tissue histopathological changes, including inflammatory cell infiltration, were significantly mitigated in DXM-treated mice. These data offer the potential therapeutic effects of DXM against cholestasis-related complications. Therefore, patients with cholestasis-induced lung injury might benefit from repurposing DXM in clinical settings.
کلیدواژه‌ها
Bile acid؛ Inflammation؛ Lung injury؛ Oxidative stress؛ Pulmonary disease
آمار
تعداد مشاهده مقاله: 66


سامانه مدیریت نشریات علمی. قدرت گرفته از سیناوب